Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Circular RNAs in diseases, Diabetes, Cardiovascular Risks, and Lipoproteins, and Alzheimer's disease research and treatments.
Association of triglyceride-glucose-related indices with all-cause and cause-specific mortality in individuals with prediabetes
Liraglutide improves senescence and ameliorating diabetic sarcopenia via the YAP-TAZ pathway
Exploring the mechanism of Jinlida granules against type 2 diabetes mellitus by an integrative pharmacology strategy
Association between urinary polycyclic aromatic hydrocarbons and risk of metabolic associated fatty liver disease
<scp>miR</scp> ‐4645‐3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5
Association between circulating levels of unsaturated fatty acids and risk for prediabetes in the NHANES 2003–2004 and 2011–2012
Identification of a novel <i>CACNA1F</i> mutation in a Chinese family with CORDX3
Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population
Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer’s disease and mild cognitive impairment: results of a meta-analysis
DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer’s Disease: A Cross-Sectional Cohort Study
Upregulation of miR-195 accelerates oxidative stress-induced retinal endothelial cell injury by targeting mitofusin 2 in diabetic rats
Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer’s Disease: A 5-Year Follow-up Study
Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer’s Disease: A 5-Year Longitudinal Study
Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment